Exobiosphere
@exobiosphere.com
Exobiosphere is a space biotech advancing drug discovery and manufacturing in microgravity, our mission is to extend and improve life on Earth and in Space. We use microgravity as a new dimension for biology to accelerate drug discovery and unlock therapies that are very hard or even impossible to develop on Earth. We’re building the world’s first standardized space-based high-throughput testing platform, allowing pharma and biotech partners to run automated experiments in orbit, at scale. By combining microgravity with advanced lab automation and bioinformatics, we create more physiologically relevant models, observe faster disease development, and reach enhanced 3D biology compared to standard in-vitro systems. The goal is simple: make space a routine, essential part of the biomedical R&D pipeline so we can bring better and faster treatments to patients.
Exobiosphere's Company Logos
Exobiosphere's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0B2F45
Tiber
11, 47, 69
203, 72, 16
84, 32, 0, 73
#FAFAFA
Alabaster
250, 250, 250
0, 0, 98
0, 0, 0, 2
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
About Exobiosphere
Exobiosphere is a space biotechnology company developing ways to support drug discovery through research in microgravity. Its Orbital High-Throughput System enables large-scale, automated testing in space, where microgravity can help create distinctive disease models. The company combines these models with high-throughput testing to investigate disease biology and help address the time, cost, and clinical-trial challenges associated with conventional drug discovery.
Exobiosphere offers services in target identification, drug development, and disease phenotyping. Its work aims to uncover molecular targets, assess potential drugs and resistance, and characterize disease traits in a unique biological environment. The company identifies oncology, ageing, neurodegeneration, radiation, inflammation, and cardiovascular health as possible therapeutic areas.
Based in Luxembourg and the United States, Exobiosphere also works with research and industry partners on space-based biomedical projects. Its announced initiatives include automated orbital drug screening and research into neurodegeneration, neuroinflammation, and cardiac tissue engineering. By connecting space-based experiments with biomedical applications on Earth, Exobiosphere seeks to advance research toward practical clinical relevance.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
